|
Research progress in newborn screening for severe combined immunodeficiency,X-linked agammaglobulinemia and spinal muscular atrophy
CHEN Chi, ZHANG Chao, ZHOU Duo, et al
2023, 38(1):
58-63.
DOI: 10.19538/j.ek2023010611
Severe combined immunodeficiency (SCID), X-linked agammaglobulinemia (XLA) and spinal muscular atrophy (SMA) are genetic birth defects that seriously affect children's health and even lead to death. Early screening, diagnosis and treatment are essential for improving prognosis and decreasing morbidity. Newborn screening is an effective measure to early identify patients with these birth defects. In some countries and regions, SCID, XLA and SMA have been added into NBS panels. As similarities in screening methods of these three diseases, the implement of combined newborn screening improves the cost-effectiveness of newborn screening.
|